Concepedia

Douglas C. Throckmorton

DC

17

Publications

1.6K

Citations

15

H-Index

1989

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Augusta University

Yale University

National Cancer Institute

Douglas C. Throckmorton is an author at United States Food and Drug Administration specializing in medicine, cell biology, and nephrology.

Top concepts

Publications per year

1989–2022

17

Publications

17

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Frank Dieterle, Frank D. Sistare, Federico Goodsaid et al. · Nature Biotechnology · 2010 · 403 citations

, , +9

PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products

Douglas C. Throckmorton, Anne P. Brogden, Brian Min et al. · Kidney International · 1995 · 174 citations

, , +7

Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gamma.

David H. Munn, Arthur C. Beall, Dongli Song et al. · The Journal of Experimental Medicine · 1995 · 172 citations · Full text

Effect of US Drug Enforcement Administration’s Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing

Christopher M. Jones, Peter Lurie, Douglas C. Throckmorton · JAMA Internal Medicine · 2016 · 127 citations · Full text

Regulation of mesangial cell growth by polypeptide mitogens. Inhibitory role of transforming growth factor beta.

F Jaffer, Christopher Saunders, P J Shultz et al. · PubMed · 1989 · 119 citations

Rows per page

1–5 of 17